Motus GI to Release Second Quarter Results and Provide a Business Update on August 11
Motus GI Holdings, Inc. (NASDAQ: MOTS) announced plans to release its second quarter financial results on August 11, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Motus GI Holdings, Inc. (NASDAQ: MOTS) announced plans to release its second quarter financial results on August 11, 2022, after market close. Management will discuss the results during a conference call at 4:30 p.m. ET. The company focuses on enhancing gastrointestinal care through innovative endoscopy solutions aimed at improving clinical outcomes and cost efficiency. A replay of the webcast will be available for 90 days on the company's website.
Positive
- Scheduled release of second quarter financial results indicates ongoing transparency and communication with investors.
Negative
- None.
Details
News Market Reaction – MOTS
The recorded move for MOTS in the trading session of this news was -2.32%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FORT LAUDERDALE, Fla., July 21, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its second quarter financial results on Thursday, August 11, 2022, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.
| Conference Call and Webcast | |
| Date and Time: | Thursday, August 11, 2022 at 4:30 p.m. ET |
| Domestic: | 1-877-407-0792 |
| International: | 1-201-689-8263 |
| Passcode: | 13730467 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1553842&tp_key=22c148327f |
A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
Investor Contact:
Troy Williams
LifeSci Advisors
(518) 221-0106
twilliams@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.